@Article{,
AUTHOR = {Neil Fleshner},
TITLE = {Defining high-risk prostate cancer: current status},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {12},
YEAR = {2005},
NUMBER = {Suppl.1},
PAGES = {14--17},
URL = {http://www.techscience.com/CJU/v12nSuppl.1/63375},
ISSN = {1488-5581},
ABSTRACT = {Defining men at high risk for prostate cancer treatment
failure and death continues to evolve. Identifying these
men allows for better disease prognostication, patient
decision treatment making and facilitates accrual for
appropriate clinical trials. Men at traditional high risk
for prostate cancer progression and death include men
with advanced clinical stage, higher levels of PSA and
Gleason pattern 4. Utilizing accepted methods of risk
stratification including nomograms can aid in case
identification. Softer risk factors such as obesity, race,
socioeconomic status, and genetic polymorphisms are
increasingly being studied. Ultimately high-throughput
genomics will aid in identification of these men.},
DOI = {}
}